The C-Reactive Protein Testing Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size for c-reactive protein testing has been experiencing consistent growth recently. The market is expected to increase from $3.45 billion in 2024 to $3.55 billion in 2025, with a compound annual growth rate (CAGR) of 2.9%.
The C-Reactive Protein Testing Global Market is projected to reach $4.35 billion in 2029, growing at a compound annual growth rate (CAGR) of 5.2%.
Download Your Free Sample of the 2025 C-Reactive Protein Testing Market Report and Uncover Key Trends Now!The key drivers in the c-reactive protein testing market are:
• Rising obesity rates
• Increasing focus on personalized medicine and biomarkers
• Growing use of telehealth and remote monitoring technologies
• An emphasis on early disease detection and lifestyle-related inflammation
The c-reactive protein testing market covered in this report is segmented –
1) By Assay Type: Enzyme-Linked Immunosorbent Assay (ELISA), Chemiluminescence Immunoassay (CLIA), Immunoturbidimetric Assays
2) By Application: Diabetes, Rheumatoid Arthritis, Cardiovascular Disease, Inflammatory Bowel Disease, Cancer, Other Applications
3) By End Use: Clinics, Hospitals, Diagnostic Laboratories
The key trends in the industrial protective footwear market are:
• Diagnostic testing advancements are emerging as a notable trend.
• Wearable health technology is shaping the future of the market.
• Technological solutions in the field are becoming more prevalent.
• Strategic collaborations and the introduction of the Industry 4.0 concept are influential trends.
Major companies in the c-reactive protein testing market are:
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Quest Diagnostics Incorporated
• Siemens AG
• Abbott Laboratories
• Aidian Oy
• Boditech Med Inc.
• Horiba Ltd.
• Laboratory Corporation
• Merck KGAA
• Randox Laboratories Limited
• Getein Biotech Inc.
• Inova Diagnostics Inc.
• Luminex Corporation
• Sekisui Diagnostics LLC
• Sysmex Corporation
• Tosoh Corporation
• Trinity Biotech Plc
• WerfenLife Group LLC
• ZEUS Scientific Inc.
• BioMérieux SA
• Biomerica Inc.
• Gold Standard Diagnostics Corp.
• Immunodiagnostic Systems Holdings PLC
• Nova Biomedical Corporation
North America was the largest region in the c-reactive protein testing market in 2024